178 related articles for article (PubMed ID: 2478247)
1. Beta human chorionic gonadotrophin in serum and urine. A marker for metastatic urothelial cancer.
Iles RK; Jenkins BJ; Oliver RT; Blandy JP; Chard T
Br J Urol; 1989 Sep; 64(3):241-4. PubMed ID: 2478247
[TBL] [Abstract][Full Text] [Related]
2. Assessment of urinary beta-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer.
Yoshimura M; Nishimura R; Murotani A; Miyamoto Y; Nakagawa T; Hasegawa K; Koizumi T; Shii K; Baba S; Tsubota N
Cancer; 1994 Jun; 73(11):2745-52. PubMed ID: 7514953
[TBL] [Abstract][Full Text] [Related]
3. Composition of intact hormone and free subunits in the human chorionic gonadotrophin-like material found in serum and urine of patients with carcinoma of the bladder.
Iles RK; Lee CL; Oliver RT; Chard T
Clin Endocrinol (Oxf); 1990 Sep; 33(3):355-64. PubMed ID: 1701369
[TBL] [Abstract][Full Text] [Related]
4. Serum and urinary levels of beta human chorionic gonadotrophin in patients with transitional cell carcinoma.
McLoughlin J; Pepera T; Bridger J; Williams G
Br J Cancer; 1991 May; 63(5):822-4. PubMed ID: 1710137
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of beta human chorionic gonadotrophin in blood serum of patients with urinary bladder tumours.
Dobrowolski ZF; Byrska B; Dolezal M
Int Urol Nephrol; 1994; 26(3):301-6. PubMed ID: 7525501
[TBL] [Abstract][Full Text] [Related]
6. Urinary concentration of human chorionic gonadotrophin and its fragments as a prognostic marker in bladder cancer.
Iles RK; Persad R; Trivedi M; Sharma KB; Dickinson A; Smith P; Chard T
Br J Urol; 1996 Jan; 77(1):61-9. PubMed ID: 8653319
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of beta-human chorionic gonadotropin in urothelial carcinoma.
Ozkardeş H; Ergen A; Ozen HA; Ayhan A; Remzi D
Int Urol Nephrol; 1991; 23(1):5-11. PubMed ID: 1718919
[TBL] [Abstract][Full Text] [Related]
8. Is beta-human chorionic gonadotrophin production by transitional cell carcinoma of the bladder a marker of aggressive disease and resistance to radiotherapy?
Moutzouris G; Yannopoulos D; Barbatis C; Zaharof A; Theodorou C
Br J Urol; 1993 Dec; 72(6):907-9. PubMed ID: 7508330
[TBL] [Abstract][Full Text] [Related]
9. [Urinary hCG beta-core fragment as a tumor marker for bladder cancer].
Yamanaka N; Kawabata G; Morisue K; Hazama M; Nishimura R
Nihon Hinyokika Gakkai Zasshi; 1993 Apr; 84(4):700-6. PubMed ID: 8492514
[TBL] [Abstract][Full Text] [Related]
10. Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and nonpregnant women.
Alfthan H; Haglund C; Dabek J; Stenman UH
Clin Chem; 1992 Oct; 38(10):1981-7. PubMed ID: 1382894
[TBL] [Abstract][Full Text] [Related]
11. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
[TBL] [Abstract][Full Text] [Related]
12. Distribution of the beta-core human chorionic gonadotrophin fragment in human body fluids.
de Medeiros SF; Amato F; Bacich D; Wang L; Matthews CD; Norman RJ
J Endocrinol; 1992 Oct; 135(1):175-88. PubMed ID: 1279092
[TBL] [Abstract][Full Text] [Related]
13. Ectopic human chorionic gonadotrophin (HCG) production: is the detection by serum analysis of HCG of clinical relevance in transitional cell carcinoma of the bladder?
Smith DJ; Evans HJ; Newman J; Chapple CR
Br J Urol; 1994 Apr; 73(4):409-12. PubMed ID: 8199829
[TBL] [Abstract][Full Text] [Related]
14. The purification and development of a radioimmunoassay for beta-core fragment of human chorionic gonadotrophin in urine: application as a marker of gynaecological cancer in premenopausal and postmenopausal women.
Lee CL; Iles RK; Shepherd JH; Hudson CN; Chard T
J Endocrinol; 1991 Sep; 130(3):481-9. PubMed ID: 1719119
[TBL] [Abstract][Full Text] [Related]
15. Trophoblastic metaplasia in urothelial carcinoma of the bladder.
Burry AF; Munn SR; Arnold EP; McRae CU
Br J Urol; 1986 Apr; 58(2):143-6. PubMed ID: 2421816
[TBL] [Abstract][Full Text] [Related]
16. Different hCG assays to measure ectopic hCG secretion in bladder carcinoma patients.
Mora J; Gascón N; Tabernero JM; Rodríguez-Espinosa J; González-Sastre F
Br J Cancer; 1996 Oct; 74(7):1081-4. PubMed ID: 8855978
[TBL] [Abstract][Full Text] [Related]
17. Urinary chorionic gonadotropin subunits and beta-core in nonpregnant women. A study of benign and malignant gynecologic disorders.
Neven P; Iles RK; Lee CL; Hudson CN; Shepherd JH; Chard T
Cancer; 1993 Jun; 71(12):4124-30. PubMed ID: 7685240
[TBL] [Abstract][Full Text] [Related]
18. Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.
Badgwell D; Lu Z; Cole L; Fritsche H; Atkinson EN; Somers E; Allard J; Moore RG; Lu KH; Bast RC
Gynecol Oncol; 2007 Sep; 106(3):490-7. PubMed ID: 17532030
[TBL] [Abstract][Full Text] [Related]
19. Measurement of urinary beta core fragment of human chorionic gonadotrophin in women with vulvovaginal malignancy and its prognostic significance.
Carter PG; Iles RK; Neven P; Ind TE; Shepherd JH; Chard T
Br J Cancer; 1995 Feb; 71(2):350-3. PubMed ID: 7530986
[TBL] [Abstract][Full Text] [Related]
20. Measurement of human chorionic gonadotropin-related immunoreactivity in serum, ascites and tumour cysts of patients with gynaecologic malignancies.
Grossmann M; Hoermann R; Gocze PM; Ott M; Berger P; Mann K
Eur J Clin Invest; 1995 Nov; 25(11):867-73. PubMed ID: 8582453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
